À la dose identique de 10 mg/j, la rosuvastatine est plus efficace que l'atorvastatine pour atteindre l'objectif de LDL-cholestérol < 1,00 g/l chez les patients à haut risque cardiovasculaire (étude ARIANE)

Autor: Danchin, N., Chadarevian, R., Gayet, J.-L., Licour, M., Valensi, P.

Publikováno v: In Annales de cardiologie et d'angeiologie 2007 56(2):82-87

Review of cannabis reimbursement by workers' compensation insurance in the U.S. and Canada.

Autor: Howard J; Office of the Director, National Institute for Occupational Safety and Health, Washington, District of Columbia, USA., Wurzelbacher S; Division of Field Studies and Engineering, National Institute for Occupational Safety and Health, Center for Workers' Compensation Studies, Cincinnati, Ohio, USA., Osborne J; Office of the Director, National Institute for Occupational Safety and Health, Atlanta, Georgia, USA., Wolf J; International Association of Accident Boards and Commissions, Middleton, Wisconsin, USA., Ruser J; Workers Compensation Research Institute, Cambridge, Massachusetts, USA., Chadarevian R; Medical Regulation and Informatics, National Council on Compensation Insurance, Boca Raton, Florida, USA.

Publikováno v: American journal of industrial medicine [Am J Ind Med] 2021 Dec; Vol. 64 (12), pp. 989-1001. Date of Electronic Publication: 2021 Sep 16.

A Review on Mitotane: A Target Therapy in Adrenocortical Carcinoma.

Autor: Flauto, Fabiano¹ (AUTHOR) fabianoflauto96@gmail.com, De Martino, Maria Cristina¹ (AUTHOR), Vitiello, Chiara¹ (AUTHOR), Pivonello, Rosario¹ (AUTHOR), Colao, Annamaria¹ (AUTHOR), Damiano, Vincenzo¹ (AUTHOR) vdamiano@unina.it

Publikováno v: Cancers. Dec2024, Vol. 16 Issue 23, p4061. 28p.

Addressing Glucocorticoid-Related Problems with the Clinical Pharmacist Collaboration in Rheumatology Practice: A Prospective Follow-Up Study.

Autor: Bahap-Kara, Melda¹ (AUTHOR) melda_610@hotmail.com, Sariyildiz, Emine² (AUTHOR), Yardimci, Gozde K.² (AUTHOR), Karadag, Omer² (AUTHOR), Bayraktar-Ekincioglu, Aygin¹ (AUTHOR)

Publikováno v: Rheumatology & Therapy. Aug2024, Vol. 11 Issue 4, p1043-1055. 13p.

Hepatic safety of ketoconazole in Cushing's syndrome: results of a Compassionate Use Programme in France.

Autor: Young J; Univ Paris-SudFaculté de Médecine Paris-Sud, Le Kremlin Bicetre, France jacques.young@aphp.fr.; Service d'Endocrinologie et des Maladies de la ReproductionAssistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin Bicetre, France.; INSERM U1185Le Kremlin-Bicetre, France., Bertherat J; Department of EndocrinologyMetabolism, and Diabetes, Institut National de la Santé et de la Recherche Médicale (INSERM) Unit 1016, Institut Cochin, Centre National de la Recherche Scientifique (CNRS) UMR 8104, Paris, France., Vantyghem MC; Service d'Endocrinologie et Maladies MétaboliquesHôpital Huriez, Centre Hospitalier Régional Universitaire de Lille, INSERM U1190, EGID, Lille, France., Chabre O; Service d'Endocrinologie-Diabétologie-NutritionCHU Grenoble-Alpes, Grenoble, France.; Faculté de Médecine Université Grenoble-AlpesGrenoble, France.; INSERM U 1036iRTSV-BCI, CEA-Grenoble, Grenoble, France., Senoussi S; HRA FranceParis, France., Chadarevian R; HRA FranceParis, France.; Service d'endocrinologie-métabolismeAssistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France., Castinetti F; Department of EndocrinologyAix Marseille Universite, CNRS UMR7286, Assistance Publique-Hopitaux de Marseille, La Conception Hospital, Marseille, France.

Publikováno v: European journal of endocrinology [Eur J Endocrinol] 2018 May; Vol. 178 (5), pp. 447-458. Date of Electronic Publication: 2018 Feb 22.